CLDN12 and cancer: Our results showed that short peptides from the first extracellular loop (Figure 1) of the protein claudin-12 are also able to reduce the migration of Jurkat cells through the tight junctions, suggesting that competitive inhibition mechanisms could be useful in the therapeutic approach applied to cancer metastasis.